Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge

Saxena, Richa, Hivert, Marie-France, Langenberg, Claudia, Tanaka, Toshiko, Pankow, James S., Vollenweider, Peter, Lyssenko, Valeriya, Bouatia-Naji, Nabila, Dupuis, Josée, Jackson, Anne U., Kao, W. H. Linda, Li, Man, Glazer, Nicole L, Manning, Alisa K, Luan, Jian'an, Stringham, Heather M, Prokopenko, Inga, Johnson, Toby, Grarup, Niels, Boesgaard, Trine W., Lecoeur, Cécile, Shrader, Peter, O'Connell, Jeffrey, Ingelsson, Erik, Couper, David J., Rice, Kenneth, Song, Kijoung, Andreasen, Camilla H, Dina, Christian, Köttgen, Anna, Le Bacquer, Olivier, Pattou, François, Taneera, Jalal, Steinthorsdottir, Valgerdur, Rybin, Denis, Ardlie, Kristin, Sampson, Michael, Qi, Lu, van Hoek, Mandy, Weedon, Michael N., Aulchenko, Yurii S., Voight, Benjamin F., Grallert, Harald, Balkau, Beverley, Bergman, Richard N., Bielinski, Suzette J, Bonnefond, Amelie, Bonnycastle, Lori L, Borch-Johnsen, Knut, Böttcher, Yvonne, Brunner, Eric, Buchanan, Thomas A., Bumpstead, Suzannah J., Cavalcanti-Proença, Christine, Charpentier, Guillaume, Chen, Yii-Der Ida, Chines, Peter S., Collins, Francis S., Cornelis, Marilyn, Crawford, Gabriel J., Delplanque, Jerome, Doney, Alex, Egan, Josephine M., Erdos, Michael R., Firmann, Mathieu, Forouhi, Nita G., Fox, Caroline S., Goodarzi, Mark O., Graessler, Jürgen, Hingorani, Aroon, Isomaa, Bo, Jørgensen, Torben, Kivimaki, Mika, Kovacs, Peter, Krohn, Knut, Kumari, Meena, Lauritzen, Torsten, Lévy-Marchal, Claire, Mayor, Vladimir, McAteer, Jarred B., Meyre, David, Mitchell, Braxton D., Mohlke, Karen L., Morken, Mario A., Narisu, Narisu, Palmer, Colin N. A., Pakyz, Ruth, Pascoe, Laura, Payne, Felicity, Pearson, Daniel, Rathmann, Wolfgang, Sandbaek, Annelli, Sayer, Avan Aihie, Scott, Laura J., Sharp, Stephen J., Sijbrands, Eric, Singleton, Andrew, Siscovick, David S., Smith, Nicholas L., Sparsø, Thomas, Swift, Amy J., Syddall, Holly, Thorleifsson, Gudmar, Tönjes, Anke, Tuomi, Tiinamaija, Tuomilehto, Jaakko, Valle, Timo T., Waeber, Gérard, Walley, Andrew, Waterworth, Dawn M., Zeggini, Eleftheria, Zhao, Jing Hua, Illig, Thomas, Wichmann, H. Erich, Wilson, James F., van Duijn, Cornelia, Hu, Frank B., Morris, Andrew D., Frayling, Timothy M., Hattersley, Andrew T., Thorsteinsdottir, Unnur, Stefansson, Kari, Nilsson, Peter, Syvänen, Ann-Christine, Shuldiner, Alan R., Walker, Mark, Bornstein, Stefan R., Schwarz, Peter, Williams, Gordon H., Nathan, David M., Kuusisto, Johanna, Laakso, Markku, Cooper, Cyrus, Marmot, Michael, Ferrucci, Luigi, Mooser, Vincent, Stumvoll, Michael, Loos, Ruth J. F., Altshuler, David, Psaty, Bruce M., Rotter, Jerome I., Boerwinkle, Eric, Hansen, Torben, Pedersen, Oluf, Florez, Jose C., McCarthy, Mark I., Boehnke, Michael, Barroso, Inês, Sladek, Robert, Froguel, Philippe, Meigs, James B., Groop, Leif, Wareham, Nicholas J. and Watanabe, Richard M. (2010) Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nature Genetics, 42 (2). pp. 142-148. ISSN 1061-4036

Full text not available from this repository. (Request a copy)

Abstract

Glucose levels 2 h after an oral glucose challenge are a clinical measure of glucose tolerance used in the diagnosis of type 2 diabetes. We report a meta-analysis of nine genome-wide association studies (n = 15,234 nondiabetic individuals) and a follow-up of 29 independent loci (n = 6,958–30,620). We identify variants at the GIPR locus associated with 2-h glucose level (rs10423928, β (s.e.m.) = 0.09 (0.01) mmol/l per A allele, P = 2.0 × 10−15). The GIPR A-allele carriers also showed decreased insulin secretion (n = 22,492; insulinogenic index, P = 1.0 × 10−17; ratio of insulin to glucose area under the curve, P = 1.3 × 10−16) and diminished incretin effect (n = 804; P = 4.3 × 10−4). We also identified variants at ADCY5 (rs2877716, P = 4.2 × 10−16), VPS13C (rs17271305, P = 4.1 × 10−8), GCKR (rs1260326, P = 7.1 × 10−11) and TCF7L2 (rs7903146, P = 4.2 × 10−10) associated with 2-h glucose. Of the three newly implicated loci (GIPR, ADCY5 and VPS13C), only ADCY5 was found to be associated with type 2 diabetes in collaborating studies (n = 35,869 cases, 89,798 controls, OR = 1.12, 95% CI 1.09–1.15, P = 4.8 × 10−18).

Item Type:	Article
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health
Depositing User:	Rhiannon Harvey
Date Deposited:	05 May 2011 14:24
Last Modified:	15 Jul 2024 02:30
URI:	https://ueaeprints.uea.ac.uk/id/eprint/29934
DOI:	10.1038/ng.521

Actions (login required)

View Item